| ASAHI KASEI KURARAY MEDICAL CO., LTD. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120031840 | METHOD FOR REDUCING AMYLOID BETA CONCENTRATION IN BLOOD - The present invention relates to a method for reducing a β-amyloid concentration in blood. Specifically, the present invention relates to a method for reducing a β-amyloid concentration in blood, comprising the steps of; removing blood out of a body, passing the blood that is removed through a hollow fiber membrane, and returning the blood that is passed through into the body, wherein the blood containing a β-amyloid-albumin complex is passed through the hollow fiber membrane to allow β-amyloid to adsorb to the hollow fiber membrane so that the β-amyloid concentration in blood is reduced. | 02-09-2012 |
| 20110295152 | PUNCTURE METHOD, INCISION NEEDLE, PUNCTURE NEEDLE, NEEDLE CAP AND INSTRUMENT FOR BLOOD PURIFICATION TREATMENT - The present invention is a method of puncturing a shunt blood vessel, using a incision needle having a pointed extremity that protrudes apically from a hypothetical angled plane formed by cutting straight through the tip of the needle at an angle, wherein the pointed extremity of the incision needle is inserted into a shunt blood vessel, thereby forming a reverse U-shaped incision on the surface of the shunt blood vessel, with the apex of the incision being on the bottom side in the direction of insertion. | 12-01-2011 |
| 20110284467 | PLASMA PURIFYING DEVICE AND METHOD OF CONTROLLING PLASMA PURIFYING DEVICE - A plasma purifying device is provided that is capable of recovering blood and plasma remaining within the plasma purifying device easily and without risk of coagulation, following completion of plasma purification therapy. The plasma purifying device has a control unit controls flow rates of the air pump and a plasma pump so that a pressure of the filtration side space of the plasma separator is higher than a pressure of the blood side space while delivering blood to the blood side space of the plasma separator by continuing to operate a blood pump without stopping following completion of plasma purification and then delivers plasma remaining in a filtration side space of a plasma separator to a blood side space of the plasma separator or to a plasma circuit by supplying air from an air pump. | 11-24-2011 |
| 20110091471 | TREATMENT METHOD FOR EPITHELIAL CANCEROUS ORGANISM - It is an object of the present invention to provide a novel method for decreasing the number of clinical cases for which trastuzumab administration is ineffective. The present invention provides a method for treating a living individual with epithelial cancer comprising:
| 04-21-2011 |
| 20100275673 | METHOD OF CALIBRATING PRESSURE MEASUREMENT UNIT - It is an object of the present invention to provide a method of calibrating a pressure measurement unit for measuring the pressure inside an extracorporeal circuit while avoiding contact with the air, in which, even when the connection between an air chamber of the pressure measurement unit and a pressure measurement means is disengaged accidentally or intentionally after the operation of changing the pressure inside the extracorporeal circuit from the initial pressure, the pressure measurement unit can be reconnected and the pressure inside the extracorporeal circuit can be measured stably. | 11-04-2010 |
| 20100258496 | POROUS HOLLOW FIBER MEMBRANE FOR TREATING BLOOD - It is intended to provide a porous hollow fiber membrane for treating blood which suffers from little mechanical damage in the course of production, transfer or handling and shows excellent fractionation properties though it is a thinned polysulfone-based hollow fiber membrane. A porous hollow fiber membrane for treating blood which comprises a polysulfone-based polymer and polyvinylpyrrolidone and has a gradient porous structure with an increase in pore size from the inside to the outside along the membrane thickness direction, characterized in that the porous structure has a membrane thickness of 25 μm or more but less than 40 μm, and fibrils having an average diameter of from 100 to 200 μm are provided in such a manner that the ratio (To/Ti) of the average outside diameter (To) along the membrane thickness direction to the average inside diameter (Ti) is adjusted to not more than 2. | 10-14-2010 |
| 20100193387 | ELECTRON BEAM STERILIZATION METHOD - [PROBLEMS] To provide an efficient sterilization method for inexpensively sterilizing a medical article having a complex shape such as a body fluid treatment device of a generally-called dry or semi-dry type by so applying an electron beam that the overall absorbed dose distribution is small and to provide its application package form. [MEANS FOR SOLVING PROBLEMS] A method for sterilizing tubular body fluid treatment devices of a dry or semi-dry type contained in an electron beam-transmitting case with an electron beam. The method is characterized in that a stack structure which includes a gap layer having an average density of 0.010 to 0.180 g/cm | 08-05-2010 |
| 20100133170 | POLYSULFONE-BASED BLOOD TREATMENT MEMBRANE AND METHOD OF PRODUCING THE SAME - A polysulfone-based blood treatment membrane that exhibits excellent antioxidant properties, excellent long-term storage stability, and a practical strength, and ensures high productivity, a polysulfone-based blood treatment membrane that exhibits excellent antioxidant properties and long-term storage stability, rarely allows endotoxins to enter a treatment liquid, exhibits a practical strength, and ensures high productivity, and a method of producing the same. A polysulfone-based blood treatment membrane includes a polysulfone-based resin, a hydrophilic polymer, and a lipophilic antioxidant, the membrane containing the lipophilic antioxidant in an amount of 30 to 76 mg per gram of the membrane, and the total amount of the lipophilic antioxidant present on the surface of the membrane being 4 to 25 mg per gram of the membrane. Another polysulfone-based blood treatment membrane contains a lipophilic antioxidant in an amount of 30 to 76 mg per gram of the membrane, wherein the inner surface of the membrane has a TOF-SIMS normalized peak intensity of the lipophilic antioxidant of 1.8×10 | 06-03-2010 |
| 20100087771 | BLOOD PURIFICATION SYSTEM - Provision of a blood purification system comprising a blood purification tubing and a blood purification apparatus particularly suitable for use in continuous hemofiltration in which in the treatment of a patient with renal disease, multiple organ failure, and the like, the amount of water removed from the patient and the amount of supply to the patient can be more accurately controlled, and in which preparation operation is easy. A blood purification system comprising a blood purification tubing and a blood purification apparatus wherein the soft tubes of flow paths connecting a first planar panel and a second planar panel, and the location of the soft tubes are selected to satisfy a formula of a predetermined condition. | 04-08-2010 |
| 20100084326 | FORMING METHOD OF BODILY FLUID PURIFICATION CASSETTE - The present invention provides a forming method capable of inexpensively forming a bodily fluid purification cassette which is reduced in size as small as possible. A bodily fluid purification cassette is detachably attached to a bodily fluid purification apparatus body. The bodily fluid purification cassette includes a synthetic resin box-like body; a basic element incorporated in the box-like body; a selective element selected from a bodily fluid purification element such as a dialyzer, a plasma exchange module and an immunoadsorbent cylinder; and bodily fluid flow passages which connects the basic element and the selective element with each other. The box-like body and the bodily fluid flow passages are formed by primary molding such that a cross section of a split-type structure has a predetermined shape, and the split-type structure is integrally formed into a cassette by secondary molding. When the bodily fluid flow passages of the split-type structure are integrally formed by secondary molding, the basic element and the selective element are liquid-tightly connected to the bodily fluid flow passages. | 04-08-2010 |
| 20090078636 | BODY FLUID TREATING FILTER DEVICE - A body fluid treating filter device capable of maintaining its treating pressure within a clinically safe pressure range even if body fluid treatment is performed over a long period and having excellent property for recovering a body fluid after the body fluid treatment is completed. A body fluid treating cylindrical filter layer is stored in a cylindrical container having two body fluid flow ports. The cylindrical filter layer is disposed so that the inner space of a container can be divided into two parts by making its both end parts fluid-tight and fixing at least one of these both end parts to the inner wall surface of the container. One of the inner spaces of the container divided by the cylindrical filter layer is allowed to communicate with the first body fluid flow port and the other of the inner spaces of the container divided by the cylindrical filter layer is allowed to communicate with the second body fluid flow port. The body fluid treating cylindrical filter device is characterized in that a bar-like flow passage resistant member extending along the center axis is installed in the hollow part of the cylindrical filter layer, and a spacer layer for flowing the body fluid of 0.7 to 3.5 mm in thickness is formed between the outer peripheral surface of the cylindrical filter layer and the container and between the inner peripheral surface of the cylindrical filter layer and the flow passage resistance member. | 03-26-2009 |
| 20090071258 | PRESSURE SENSOR FOR EXTRACORPOREAL CIRCULATING CIRCUIT - A pressure sensor for an extracorporeal circulating circuit includes a liquid chamber, a pressure measuring means, and a liquid flow path. The liquid chamber includes a reference surface not deformed by a pressure in the extracorporeal circulating circuit, a deforming surface disposed separated from the reference surface and deformed at least partially by a pressure in the extracorporeal circulating circuit, a first connection surface that joins the deforming surface with the reference surface to form a closed liquid-tight space inside them and is not deformed by a pressure in the extracorporeal circulating circuit, a liquid inflowing port provided in the side surface of the first connection surface, and a liquid outflowing port disposed away by ½ to less than one round from the inflowing port in the flowing direction of liquid introduced along the inner periphery of the side surface of the first connection surface. The pressure measuring means measures the deformation amount of the deforming surface, and is disposed outside the liquid chamber; and the liquid flow path is liquid-tightly connected with the liquid inflowing port so that liquid to be introduced into the liquid chamber flows in along the inner periphery of the side surface of the first connection surface. | 03-19-2009 |
